Page last updated: 2024-12-08

diospyrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diospyrin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID308140
CHEMBL ID242550
CHEBI ID4633
SCHEMBL ID24684659
MeSH IDM0128081

Synonyms (25)

Synonym
1',5-dihydroxy-3',7-dimethyl-(2,2'-binaphthalene)-1,4,5',8'-tetrone
ccris 7335
(2,2'-binaphthalene)-1,4,5',8'-tetrone, 1',5-dihydroxy-3',7-dimethyl-
brn 1297556
nsc 208730
euclein
nsc-208730
nsc208730
[2,4,5',8'-tetrone, 1',5-dihydroxy-3',7-dimethyl-
5,5'-dihydroxy 7,7'-binaphthoquinone
5-hydroxy-2-(1-hydroxy-3-methyl-5,8-dioxo-2-naphthyl)-7-methyl-naphthalene-1,4-dione
diospyrin
28164-57-0
chebi:4633 ,
CHEMBL242550
5-hydroxy-6-(5-hydroxy-7-methyl-1,4-dioxonaphthalen-2-yl)-7-methylnaphthalene-1,4-dione
o0iqz8b2r7 ,
unii-o0iqz8b2r7
bdbm93038
WRFTYMHHWSAKSK-UHFFFAOYSA-N
[2,2'-binaphthalene]-1,4,5',8'-tetrone, 1',5-dihydroxy-3',7-dimethyl-
DTXSID30182429
Q27106425
1',5-dihydroxy-3',7-dimethyl-2,2'-binaphthalene-1,4,5',8'-tetrone
SCHEMBL24684659

Research Excerpts

Overview

Diospyrin is a plant product that has significant inhibitory effect on the growth of Leishmania donovani promastigotes.

ExcerptReferenceRelevance
"Diospyrin is a plant product that has significant inhibitory effect on the growth of Leishmania donovani promastigotes. "( Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
Das, A; Hazra, B; Majumder, HK; Mittra, B; Ray, S, 1998
)
3.19

Actions

ExcerptReferenceRelevance
"Some diospyrin derivatives inhibit either the first or the second catalytic step of splicing but not spliceosome assembly, whereas diospyrin itself prevents the formation of full spliceosome."( Selective inhibition of topoisomerase I and various steps of spliceosome assembly by diospyrin derivatives.
Bailly, C; Bakkour, N; Baldeyrou, B; Hazra, B; Laine, W; Lansiaux, A; Soret, J; Tazi, J; Zekri, L, 2005
)
1.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
ring assemblyTwo or more cyclic systems (single rings or fused systems) which are directly joined to each other by double or single bonds are named ring assemblies when the number of such direct ring junctions is one less than the number of cyclic systems involved.
hydroxy-1,4-naphthoquinoneAny member of the class of 1,4-naphthoquinones in which the naphthoquinone moiety is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA gyrase subunit BMycobacterium tuberculosis H37RvIC50 (µMol)15.00000.01502.467610.0000AID1335289
DNA gyrase subunit AMycobacterium tuberculosis H37RvIC50 (µMol)15.00000.01503.477310.0000AID1335289; AID1799875
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (39)

Assay IDTitleYearJournalArticle
AID510607Cytotoxicity against human A375 cells2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID1335290Inhibition of Escherichia coli DNA gyrase assessed as inhibition of DNA supercoiling activity using relaxed pBR322 as substrate incubated for 30 mins in presence of ATP by ethidium bromide staining based agarose gel electrophoresis2016European journal of medicinal chemistry, Nov-29, Volume: 124Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
AID364573Cytotoxicity against human PBMC cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID364570Cytotoxicity against mouse Ehrlich ascites carcinoma cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID510604Cytotoxicity against human HL60 cells2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID510608Cytotoxicity against human Hep2 cells2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID364567Toxicity in single ip dosed Swiss A mouse2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID1858846Antimalarial activity against Plasmodium falciparum by 96-well microtitre plate method based scintillation counting analysis2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
AID302001Activity of Mycobacterium tuberculosis mycothiol reductase2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
AID364563Antitumor activity against mouse Ehrlich ascites carcinoma cells xenografted in Swiss A mouse assessed as inhibition of tumor growth at 1 mg/kg, ip administered five doses in alternate days measured after 16 days2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID364569Effect on alkaline phosphatase activity in Swiss A mouse xenografted with mouse Ehrlich ascites carcinoma cells assessed as umole of PNPP hydrolysed per minute per decilitre of serum at 1 mg/kg, ip administered five doses in alternate days measured after 2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID510609Cytotoxicity against mouse EAC cells2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID364572Cytotoxicity against human Hep2 cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID510606Cytotoxicity against human PBMC2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID364571Cytotoxicity against human A375 cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID301998Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
AID295629Cytotoxicity against human PBMCs after 24 hrs by MTT assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Synthesis and antiproliferative activity of some novel derivatives of diospyrin, a plant-derived naphthoquinonoid.
AID295627Cytotoxicity against human Hep2 cells after 24 hrs by MTT assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Synthesis and antiproliferative activity of some novel derivatives of diospyrin, a plant-derived naphthoquinonoid.
AID1335291Inhibition of Staphylococcus aureus WCUH29 DNA gyrase expressed in Escherichia coli Rosetta 2 (DE3) pLysS cells assessed as inhibition of DNA supercoiling activity using relaxed pBR322 as substrate incubated for 30 mins in presence of ATP by ethidium brom2016European journal of medicinal chemistry, Nov-29, Volume: 124Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
AID364581Cytotoxicity against human K562 cells by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID1718903Cytotoxicity against human NFF cells assessed as reduction in cell viability after 48 hrs by resazurin dye based assay2020Journal of natural products, 12-24, Volume: 83, Issue:12
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
AID302000Selectivity index, ratio of IC50 for Vero cells to MIC of Mycobacterial tuberculosis H37Rv2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
AID364565Antitumor activity against mouse Ehrlich ascites carcinoma cells xenografted in Swiss A mouse assessed as increase in life span at 1 mg/kg, ip administered five doses in alternate days relative to control2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID364580Cytotoxicity against human HL60 cells by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID295626Cytotoxicity against human A375 cells after 24 hrs by MTT assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Synthesis and antiproliferative activity of some novel derivatives of diospyrin, a plant-derived naphthoquinonoid.
AID1335289Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as inhibition of DNA supercoiling activity using relaxed pBR322 as substrate incubated for 30 mins in presence of ATP by ethidium bromide staining based agarose gel electrophoresis2016European journal of medicinal chemistry, Nov-29, Volume: 124Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
AID364582Cytotoxicity against human MCF7 cells by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID510615Inhibition of human recombinant Glutathione S-transferase2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID295628Cytotoxicity against mouse EAC cells after 24 hrs by MTT assay2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Synthesis and antiproliferative activity of some novel derivatives of diospyrin, a plant-derived naphthoquinonoid.
AID364568Effect on serum LDH activity in Swiss A mouse xenografted with mouse Ehrlich ascites carcinoma cells assessed as LDH unit at 1 mg/kg, ip administered five doses in alternate days measured after 16 days relative to control2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID510605Cytotoxicity against human K562 cells2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Anti-cancer activities of diospyrin, its derivatives and analogues.
AID364583Cytotoxicity against human A431 cells by MTT assay2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID1718902Antiproliferative activity against mouse NS-1 cells assessed as reduction in cell viability after 48 hrs by resazurin dye based assay2020Journal of natural products, 12-24, Volume: 83, Issue:12
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
AID302002Ratio of kcat to Km of Mycobacterium tuberculosis mycothiol reductase2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
AID364562Antitumor activity against mouse Ehrlich ascites carcinoma cells xenografted in Swiss A mouse assessed as increase in survival time at 1 mg/kg, ip administered five doses in alternate days2008European journal of medicinal chemistry, Sep, Volume: 43, Issue:9
Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
AID1718901Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as reduction in DNA supercoiled DNA formation incubated for 30 mins by SDS-PAGE analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
AID1718904Selectivity index, ratio of IC50 for cytotoxicity against human NFF cells to IC0 for antiproliferative activity against mouse NS-1 cells2020Journal of natural products, 12-24, Volume: 83, Issue:12
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
AID301999Cytotoxicity against Vero cells after 48 hrs by XTT method2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
AID1799875Enzyme Assay from Article 10.1074/jbc.M112.419069: \\The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.\\2013The Journal of biological chemistry, Feb-15, Volume: 288, Issue:7
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.26)18.7374
1990's1 (2.63)18.2507
2000's21 (55.26)29.6817
2010's11 (28.95)24.3611
2020's3 (7.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.95 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (10.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (89.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]